News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
379,629 Results
Type
Article (18533)
Company Profile (290)
Press Release (360806)
Section
Business (111551)
Career Advice (436)
Deals (21559)
Drug Delivery (53)
Drug Development (61663)
Employer Resources (52)
FDA (9312)
Job Trends (7627)
News (202218)
Policy (16934)
Tag
Academia (1253)
Alliances (28469)
Alzheimer's disease (1042)
Approvals (9307)
Artificial intelligence (135)
Bankruptcy (196)
Best Places to Work (6783)
Biotechnology (238)
Breast cancer (168)
Cancer (1363)
Cardiovascular disease (108)
Career advice (380)
CAR-T (108)
Cell therapy (312)
Clinical research (50031)
Collaboration (520)
Compensation (210)
COVID-19 (1402)
C-suite (133)
Cystic fibrosis (86)
Data (1402)
Diabetes (147)
Diagnostics (3041)
Earnings (46877)
Events (61279)
Executive appointments (405)
FDA (10008)
Funding (484)
Gene therapy (221)
GLP-1 (415)
Government (1943)
Healthcare (9814)
Infectious disease (1474)
Inflammatory bowel disease (113)
IPO (11449)
Job creations (1232)
Job search strategy (338)
Layoffs (219)
Legal (2935)
Lung cancer (195)
Lymphoma (87)
Manufacturing (146)
Medical device (6209)
Medtech (6211)
Mergers & acquisitions (10464)
Metabolic disorders (412)
Neuroscience (1385)
NextGen: Class of 2025 (2951)
Non-profit (1390)
Northern California (1644)
Obesity (226)
Opinion (138)
Parkinson's disease (97)
Patents (121)
People (31725)
Phase I (16698)
Phase II (22732)
Phase III (15646)
Pipeline (630)
Postmarket research (1272)
Preclinical (6783)
Radiopharmaceuticals (225)
Rare diseases (285)
Real estate (2121)
Regulatory (13248)
Research institute (1207)
Series A (96)
Southern California (1437)
Startups (2243)
United States (13703)
Vaccines (284)
Weight loss (139)
Date
Today (68)
Last 7 days (441)
Last 30 days (1992)
Last 365 days (26592)
2025 (3369)
2024 (27028)
2023 (29940)
2022 (36110)
2021 (38021)
2020 (34000)
2019 (24006)
2018 (17755)
2017 (19632)
2016 (17026)
2015 (20753)
2014 (15145)
2013 (11201)
2012 (11470)
2011 (12023)
2010 (11391)
Location
Africa (293)
Asia (26233)
Australia (5639)
California (3740)
Canada (1395)
China (320)
Colorado (152)
Connecticut (184)
Europe (50826)
Florida (499)
Georgia (122)
Illinois (251)
Indiana (136)
Japan (100)
Maryland (497)
Massachusetts (2930)
Michigan (90)
Minnesota (175)
New Jersey (1080)
New York (1036)
North Carolina (631)
Northern California (1644)
Ohio (113)
Pennsylvania (785)
South America (450)
Southern California (1437)
Texas (492)
Washington State (397)
379,629 Results for "bicycle therapeutics limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
Genetown
Bicycle Therapeutics to Participate in Upcoming June 2024 Investor Conferences
Bicycle Therapeutics plc, a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in the following investor conferences in June.
June 3, 2024
·
2 min read
Press Releases
Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2025
February 4, 2025
·
2 min read
Press Releases
Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones
January 13, 2025
·
10 min read
Press Releases
Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
November 12, 2024
·
1 min read
Press Releases
Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts
December 10, 2024
·
6 min read
Business
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported recent business progress and financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
9 min read
Press Releases
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 3, 2025
January 6, 2025
·
2 min read
Deals
Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing
Bicycle Therapeutics plc today announced that the company has entered into a securities purchase agreement with certain existing and new accredited investors to issue and sell an aggregate of 25,933,706 American Depositary Shares.
May 23, 2024
·
6 min read
1 of 37,963
Next
